Literature DB >> 31041657

Prion Efficiently Replicates in α-Synuclein Knockout Mice.

Edoardo Bistaffa1, Martina Rossi2, Chiara Maria Giulia De Luca1,2, Federico Cazzaniga1, Olga Carletta1, Ilaria Campagnani1, Fabrizio Tagliavini1, Giuseppe Legname2, Giorgio Giaccone1, Fabio Moda3.   

Abstract

Prion diseases are a group of neurodegenerative disorders associated with the conformational conversion of the cellular prion protein (PrPC) into an abnormal misfolded form named PrPSc. Other than accumulating in the brain, PrPSc can bind PrPC and force it to change conformation to PrPSc. The exact mechanism which underlies the process of PrPC/PrPSc conversion still needs to be defined and many molecules or cofactors might be involved. Several studies have documented an important role of PrPC to act as receptor for abnormally folded forms of α-synuclein which are responsible of a group of diseases known as synucleinopathies. The presence of PrPC was required to promote efficient internalization and spreading of abnormal α-synuclein between cells. In this work, we have assessed whether α-synuclein exerts any role in PrPSc conversion and propagation either in vitro or in vivo. Indeed, understanding the mechanism of PrPC/PrPSc conversion and the identification of cofactors involved in this process is crucial for developing new therapeutic strategies. Our results showed that PrPSc was able to efficiently propagate in the brain of animals even in the absence of α-synuclein thus suggesting that this protein did not act as key modulator of prion propagation. Thus, α-synuclein might take part in this process but is not specifically required for sustaining prion conversion and propagation.

Entities:  

Keywords:  PMCA; Prions; RML; α-Synuclein

Mesh:

Substances:

Year:  2019        PMID: 31041657     DOI: 10.1007/s12035-019-1602-6

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  69 in total

1.  The chaperone activity of α-synuclein: Utilizing deletion mutants to map its interaction with target proteins.

Authors:  Agata Rekas; Keun Jae Ahn; Jongsun Kim; John A Carver
Journal:  Proteins       Date:  2012-02-10

2.  Influence of the prion protein and the apolipoprotein E genotype on the Creutzfeldt-Jakob Disease phenotype.

Authors:  B Van Everbroeck; E A Croes; P Pals; B Dermaut; G Jansen; C M van Duijn; M Cruts; C Van Broeckhoven; J J Martin; P Cras
Journal:  Neurosci Lett       Date:  2001-11-02       Impact factor: 3.046

3.  Immunohistochemical detection of apolipoprotein E within prion-associated lesions in squirrel monkey brains.

Authors:  S Nakamura; F Ono; M Hamano; K Odagiri; M Kubo; K Komatsuzaki; K Terao; M Shinagawa; K Takahashi; Y Yoshikawa
Journal:  Acta Neuropathol       Date:  2000-10       Impact factor: 17.088

4.  Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.

Authors:  William Dauer; Nikolai Kholodilov; Miquel Vila; Anne-Cecile Trillat; Rose Goodchild; Kristin E Larsen; Roland Staal; Kim Tieu; Yvonne Schmitz; Chao Annie Yuan; Marcelo Rocha; Vernice Jackson-Lewis; Steven Hersch; David Sulzer; Serge Przedborski; Robert Burke; Rene Hen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-10       Impact factor: 11.205

5.  Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration.

Authors:  Sreeganga Chandra; Gilbert Gallardo; Rafael Fernández-Chacón; Oliver M Schlüter; Thomas C Südhof
Journal:  Cell       Date:  2005-11-04       Impact factor: 41.582

6.  Synthetic Prion Selection and Adaptation.

Authors:  Edoardo Bistaffa; Fabio Moda; Tommaso Virgilio; Ilaria Campagnani; Chiara Maria Giulia De Luca; Martina Rossi; Giulia Salzano; Giorgio Giaccone; Fabrizio Tagliavini; Giuseppe Legname
Journal:  Mol Neurobiol       Date:  2018-08-03       Impact factor: 5.590

Review 7.  The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.

Authors:  Maddalena Costanzo; Chiara Zurzolo
Journal:  Biochem J       Date:  2013-05-15       Impact factor: 3.857

Review 8.  Alpha-synuclein structure, functions, and interactions.

Authors:  Fatemeh Nouri Emamzadeh
Journal:  J Res Med Sci       Date:  2016-05-09       Impact factor: 1.852

Review 9.  The biological function of the cellular prion protein: an update.

Authors:  Marie-Angela Wulf; Assunta Senatore; Adriano Aguzzi
Journal:  BMC Biol       Date:  2017-05-02       Impact factor: 7.431

10.  Involvement of Cellular Prion Protein in α-Synuclein Transport in Neurons.

Authors:  Laura Urrea; Miriam Segura-Feliu; Masami Masuda-Suzukake; Arnau Hervera; Lucas Pedraz; José Manuel García Aznar; Miquel Vila; Josep Samitier; Eduard Torrents; Isidro Ferrer; Rosalina Gavín; Masato Hagesawa; José Antonio Del Río
Journal:  Mol Neurobiol       Date:  2017-02-22       Impact factor: 5.590

View more
  1 in total

1.  Monomeric a-synuclein (aS) inhibits amyloidogenesis of human prion protein (hPrP) by forming a stable aS-hPrP hetero-dimer.

Authors:  Satoshi Yamashita; Yuji O Kamatari; Ryo Honda; Ayumi Niwa; Hiroyuki Tomiata; Akira Hara; Kazuo Kuwata
Journal:  Prion       Date:  2021-12       Impact factor: 3.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.